We are live on
!
Find out more
GKIM
GW&K Investment Management Portfolio holdings
AUM
$11.3B
1-Year Est. Return
31.98%
This Fund
S&P 500
This Quarter
Est. Return
-1.98%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$9.06B
AUM Growth
-$208M
(-2.2%)
Cap. Flow
+$200M
Cap. Flow
% of AUM
2.21%
Top 10 Holdings %
Top 10 Hldgs %
12.14%
Holding
854
New
14
Increased
123
Reduced
229
Closed
455
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$46.1M |
| 2 |
Lincoln Electric
LECO
|
+$32M |
| 3 |
EastGroup Properties
EGP
|
+$30.6M |
| 4 |
NSA
National Storage Affiliates Trust
NSA
|
+$29.3M |
| 5 |
Cognex
CGNX
|
+$27.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$35.3M |
| 2 |
CVET
Covetrus, Inc. Common Stock
CVET
|
+$35.2M |
| 3 |
PSB
PS Business Parks, Inc.
PSB
|
+$30.9M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$29.7M |
| 5 |
Diamondback Energy
FANG
|
+$28.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.92% |
| 2 | Healthcare | 16.87% |
| 3 | Technology | 15.88% |
| 4 | Financials | 12.87% |
| 5 | Consumer Discretionary | 11.95% |
Similar funds
BHCM
VLKIM
ERSOT
DCP
DWM
GIM
MIFH
GW&K Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, GW&K Investment Management held 854 positions worth $9.06B, down 2.2% from $9.27B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
GW&K Investment Management's Q3 2022 filing shows 14 new, 123 increased, 229 reduced and 455 closed positions. Its largest new stake was Lincoln Electric: 236,966 shares worth $29.8M. The largest sale was ChemoCentryx, Inc., an estimated $35.3M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
- GW&K Investment Management's largest Q3 2022 buy was Lincoln Electric: 236,966 shares worth $29.8M.
- GW&K Investment Management added most to Intra-Cellular Therapies Inc. in Q3 2022, an estimated $46.1M increase.
- GW&K Investment Management's biggest Q3 2022 reduction was ChemoCentryx, Inc., cutting an estimated $35.3M.
- GW&K Investment Management fully exited PS Business Parks, Inc. in Q3 2022, selling an estimated $30.9M.
- GW&K Investment Management's ten largest holdings make up 12% of its $9.06B portfolio in Q3 2022.
- GW&K Investment Management opened 14 new positions and closed 455 in Q3 2022.
- GW&K Investment Management's portfolio value fell 2.2% quarter-over-quarter to $9.06B.
Based on GW&K Investment Management's 13F filing for Q3 2022, filed 9 Nov 2022.